Cell Research Co. Strikes Deal To End Clinical Data Suit
Canadian stem cell research company Hemostemix Inc. has agreed to settle claims made in its suit against a consultant company over clinical data relating to a treatment for an inadequate blood...To view the full article, register now.
Already a subscriber? Click here to view full article